Growth inhibition of yeast strains with defined genetic alterations is measured as a screen for potential anti-cancer activity. Selected strains with alterations in DNA damage repair or cell cycle control were exposed to compounds and growth inhibition was measured relative to vehicle treated controls. The strain used in this assay is bub3
Comment:
These data are a subset of the data from the NCI yeast anticancer drug screen. Compounds are identified by the NCI NSC number. In the Seattle Project numbering system, the bub3 strain is SPY number 50779 Compounds with inhibition of growth(giprct) >= 70% were considered active. Activity score was based on increasing values of giprct.
Result Definitions:
TID
Name
Description
Type
Unit
Outcome
The BioAssay activity outcome
String
Score
The BioAssay activity ranking score
Integer
1
conc
concentration tested, unit: micromolar
Float
uM
2
giprct
Inhibiton of growth compared to untreated controls (%)